SUMMARY
Hypomagnesaemia is common in critically ill 1 and hospitalized patients 2 . It is particularly common in patients with Crohn's disease and short bowel syndrome as magnesium is absorbed in the jejunum and ileum 3, 4 . Although deficiency is known to cause neuromuscular excitability and rarely convulsions, this has not been reported in a case with short bowel syndrome. We report a case and describe our management, which included home intravenous fluid and magnesium therapy even though adequate nutrition could be absorbed enterally.
CASE HISTORY
A 69-year-old woman with Crohn's disease presented to the accident and emergency department complaining of severe nausea, vomiting, fatigue and thirst. She had had a total colectomy performed 10 years previously and more recently, further small bowel resection and ileostomy fashioned for the recurrence of disease two months prior to this presentation. On examination she looked malnourished, her weight was 38 kg (normal predicted 58 kg). Her blood pressure was 100/70 mmHg and heart rate 100/min. She was hypovolaemic and had a low urine output. Her abdomen was non-tender and bowel sounds were present. Her ileostomy bag was noted to fill rapidly and she confirmed that she was changing the bag six to 10 times a day. Her haemoglobin concentration was 12 g/dl (11.5 to 16.5 g/dl) and lymphocyte count 0.43 x 10 9 /l (1.5 to 4 x 10 9 /l). Serum albumin was 38 g/l (34 to 50 g/l). She was admitted to hospital, with a working diagnosis of salt, water and nutritional depletion due to a high output ileostomy and short bowel syndrome. She was commenced on intravenous (IV) fluid and electrolyte replacement followed by oral rehydration, and diet. Her condition settled and she was discharged home after four days.
She was readmitted on two further occasions with similar symptoms and received similar therapy. On the first of these her serum magnesium was 0.17 mmol/l (0.65 to 1.05 mmol/l). She was commenced on oral magnesium oxide and 1-alpha vitamin D. On the third admission, two months after initial presentation, she had a generalized seizure lasting three minutes and was subsequently admitted to the High Dependency Unit in a post-ictal state. Her magnesium was extremely low at 0.09 mmol/l. Table I summarizes her biochemistry. A total serum calcium corrected for albumin taken at the same time was slightly below normal at 1.91 mmol/l (2.03 to 2.63 mmol/l). Immediate management included intravenous magnesium (8 mmol stat and 30 mmol over 12 hours). Subsequently daily IV replacement with 20 mmol magnesium was necessary to maintain levels near to or within the normal range.
To facilitate discharge home she had a Hickman catheter inserted through which she could selfadminister two litres of normal saline and 20 mmol magnesium daily. She continued a modified oral diet and was reviewed in outpatients on a two-weekly basis. She received two litres of a parenteral nutrition preparation containing glutamine at each outpatient visit for the first six months. This therapy was continued for 18 months at which time she was admitted electively to reassess the ongoing need for daily intravenous saline and magnesium. These were discontinued and after five days, 24-hours urine and ileostomy (faecal) collection were performed. This confirmed on-going inappropriate faecal magnesium loss and renal conservation. Data from the urine and ileostomy collection are summarized in Table 2 .
A failure of enteral re-adaptation associated with ongoing sodium, water and magnesium loss was therefore evident, despite barium follow-through demonstration of apparent adequate residual gut length, estimated to be approximately 200 cm. Her dependence on longterm IV supplementation was confirmed.
DISCUSSION
This patient had a long history of Crohn's disease that resulted in a short bowel syndrome following multiple surgical resections with a residual small bowel length of approximately 200 cm. Such patients have difficulty absorbing adequate macronutrients and in particular have further problems with large stomal losses of water, sodium, and magnesium 5, 6 . However patients with 100 to 200 cm small bowel can absorb adequate water, electrolytes and nutrition orally without the need for parenteral supplementation, and benefit from the use of drugs to slow gut transit time (codeine phosphate) and drugs to decrease gut secretions (H2 antagonists, octreotide, proton pump inhibitors) 7 . 1-alpha-hydroxylated vitamin D metabolites and oral magnesium effectively reversed symptoms due to severe hypomagnesaemia in seven patients following extensive resection of small bowel 4 . Sial et al 8 report a case with approximately 100 cm remaining jejenum where high calorie, oral rehydration and vitamin and mineral supplementation were used effectively to maintain a reasonable nutritional state without the need for longterm intravenous therapy.
Despite such therapy this patient developed hypomagnesaemia to such a degree that she suffered a grand mal seizure that required and responded to IV magnesium. The co-existence of hypocalcaemia plays a key role in the clinical features of magnesium depletion 9, 10 . The common link is parathyroid hormone. As serum magnesium decreases, parathyroid hormone secretion increases, thus enhancing magnesium absorption in the kidney and gut and release from bone 9, 10 . However, when magnesium levels reach 0.4 mmol/l or less, both secretion and peripheral action of parathyroid hormone are inhibited 10 . In this patient with such severe hypomagnesaemia, concurrent severe hypocalcaemia would also have been expected but did not occur. The neuromuscular excitability and seizure activity are often attributed to the concurrent hypocalcaemia 10 , which in this case was not marked. Hypomagnesaemia occurred in isolation and would seem the primary cause of the generalized seizure.
Morris et al 11 have reported that magnesium blocks N-methyl-D-aspartate receptors in neurons and these receptors are normally activated by glutamate and/or aspartate which represent the principal neurotransmitters for excitatory synaptic transmission in vertebrate central nervous system. These glutaminergic synapses have a critical role in all epileptic phenomena 12 and we propose the seizure mechanism that occurred was likely due to the uninhibited glutaminergic transmission at these receptors due to a primary magnesium deficiency.
The expectation that adaptation of gut may occur 13, 14 prompted an in-hospital review of parenteral fluid and magnesium therapy 18 months after initial presentation. After five days of oral diet alone, a 24-hour faecal and urinary collection was taken. Fluid loss continued via the stoma with the development of marked sodium retention and a pre-renal state ( Table 2 ). The stoma losses of magnesium continued while renal loss was negligible, showing renal conservation. It has been shown that urinary magnesium declines before serum magnesium and is an earlier and more reliable indicator of evolving magnesium deficiency 15 . The result of this in-hospital review reaffirmed not only her need for parenteral fluid, but also her dependence on parenteral magnesium replacement.
Magnesium deficiency is common in patients with malabsorption and short bowel syndrome. In those patients not requiring total parenteral nutrition, the indications for fluid and magnesium replacement need to be judged on an individual patient basis. A considerable proportion of those will be able to absorb adequate nutrition enterally and seem capable of maintaining normal or near normal serum magnesium with oral supplementation alone. The occurrence of marked hypomagnesaemia in such a patient as an isolated deficiency, resulting in a generalized convulsion, has not previously been reported. This report demonstrates that convulsant hypomagnesaemia can occur in this group of patients.
